Maurizio R Averna Selected Research

Maurizio R Averna Research Topics

Disease

9	Hypertriglyceridemia 12/2023 - 06/2004
8	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2014 - 03/2008
7	Hypobetalipoproteinemias (Hypobetalipoproteinemia) 07/2022 - 06/2006
6	Homozygous Familial Hypercholesterolemia 01/2020 - 01/2013
5	Coronary Artery Disease (Coronary Atherosclerosis) 12/2023 - 10/2005
5	Pancreatitis 01/2020 - 06/2004
5	Diabetes Mellitus 02/2017 - 04/2006
4	Alzheimer Disease (Alzheimer's Disease) 08/2006 - 12/2002
4	Celiac Disease (Celiac Sprue) 04/2006 - 09/2002
3	Fatty Liver 07/2022 - 06/2006
3	Insulin Resistance 02/2017 - 06/2004
3	Hypercholesterolemia 06/2014 - 01/2006
3	Vascular Diseases (Vascular Disease) 06/2014 - 08/2005
3	Myocardial Infarction 11/2009 - 02/2002
2	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 02/2017 - 03/2006
2	2 Familial Hypobetalipoproteinemia 02/2017 - 01/2017
2	Cardiovascular Diseases (Cardiovascular Disease) 06/2014 - 11/2009
2	Obesity 09/2013 - 12/2002
2	Liver Cirrhosis (Hepatic Cirrhosis) 08/2013 - 06/2003
2	Atherosclerosis 04/2013 - 05/2006
1	Inborn Genetic Diseases (Disease, Hereditary) 07/2022
1	Hyperlipoproteinemia Type III (Broad Beta Disease) 01/2018
1	Hyperlipoproteinemia Type I (Lipoprotein Lipase Deficiency, Familial) 01/2017
1	Wolman Disease (Wolman's Disease) 01/2017
1	Hepatocellular Carcinoma (Hepatoma) 03/2016
1	Acute Disease 03/2016
1	Chronic Kidney Failure (Chronic Renal Failure) 07/2015
1	Inflammation (Inflammations) 01/2014
1	Neoplasms (Cancer) 08/2013
1	Carcinoma (Carcinomatosis) 08/2013
1	Fibrosis (Cirrhosis) 08/2013
1	Non-alcoholic Fatty Liver Disease 04/2013
1	Abetalipoproteinemia (Bassen Kornzweig Syndrome) 04/2011
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 04/2011

Drug/Important Bio-Agent (IBA)

8	Apolipoproteins B (ApoB)IBA 07/2022 - 06/2006
8	CholesterolIBA 07/2022 - 12/2002
8	Triglycerides (Triacylglycerol)IBA 01/2020 - 05/2006
7	oxidized low density lipoproteinIBA 12/2023 - 03/2006
7	LipidsIBA 01/2018 - 02/2002
6	LDL CholesterolIBA 07/2022 - 04/2012
6	Lipoproteins (Lipoprotein)IBA 01/2017 - 05/2006
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2023 - 01/2006
5	ApolipoproteinsIBA 07/2022 - 05/2006
5	BMS201038IBA 01/2020 - 01/2013
4	Nonsense Codon (Nonsense Mutation)IBA 01/2017 - 11/2009
4	HDL CholesterolIBA 03/2016 - 10/2005
4	LDL Lipoproteins (beta Lipoproteins)IBA 07/2015 - 02/2002
3	microsomal triglyceride transfer proteinIBA 01/2020 - 09/2014
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2014 - 11/2007
3	Lipase (Acid Lipase)FDA Link 06/2011 - 04/2006
2	Apolipoproteins E (ApoE)IBA 07/2015 - 05/2006
2	Glucose (Dextrose)FDA LinkGeneric 03/2008 - 06/2004
2	AutoantibodiesIBA 06/2004 - 08/2003
2	TransglutaminasesIBA 08/2003 - 09/2002
1	O(4)-methylthymidine triphosphateIBA 07/2022
1	FurinIBA 01/2017
1	AngiopoietinsIBA 01/2017
1	Proprotein Convertase 9IBA 01/2017
1	AlbuminsIBA 03/2016
1	Myristic Acid (Tetradecanoic Acid)IBA 03/2016
1	Detergents (Detergent)IBA 03/2016
1	SolventsIBA 03/2016
1	Proteoglycans (Proteoglycan)IBA 03/2016
1	Carrier Proteins (Binding Protein)IBA 12/2015
1	ElementsIBA 12/2015
1	Cyclic AMP (AMP, Cyclic)IBA 12/2015
1	Heparin (Liquaemin)FDA LinkGeneric 07/2015
1	HDL LipoproteinsIBA 07/2015
1	AntioxidantsIBA 07/2014
1	PCSK9 InhibitorsIBA 06/2014
1	mipomersenIBA 06/2014
1	NitritesIBA 01/2014
1	NitratesIBA 01/2014
1	Thiobarbituric Acid Reactive SubstancesIBA 01/2014
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2014
1	Atrial Natriuretic Factor (ANF)IBA 09/2013
1	Matrix Metalloproteinases (MMPs)IBA 08/2013
1	Tissue Inhibitor of Metalloproteinase-2IBA 08/2013
1	Tissue Inhibitor of Metalloproteinase-1IBA 08/2013
1	GelatinasesIBA 08/2013
1	Metalloproteases (Metalloproteinases)IBA 08/2013
1	Adenosine Triphosphate (ATP)IBA 04/2013
1	Proteins (Proteins, Gene)FDA Link 01/2013
1	Factor VII (Proconvertin)IBA 04/2012
1	SterolsIBA 06/2011
1	HomocysteineIBA 11/2009
1	C-Reactive ProteinIBA 11/2009
1	CD40 Ligand (CD40L)IBA 11/2009
1	Pravastatin (Pravachol)FDA LinkGeneric 11/2007
1	LigandsIBA 11/2007
1	Atorvastatin (Lipitor)FDA Link 11/2007
1	8-epi-prostaglandin F2alphaIBA 11/2007
1	Estrogen Receptor alphaIBA 08/2006
1	Fatty Acids (Saturated Fatty Acids)IBA 06/2006

Therapy/Procedure

6	Therapeutics 02/2017 - 01/2006
1	Mediterranean Diet 03/2016
1	Plasma Exchange 03/2016
1	Renal Dialysis (Hemodialysis) 07/2015
1	Fat-Restricted Diet (Diet, Fat Restricted) 09/2014
1	Blood Component Removal (Apheresis) 09/2014